BC Week In Review | Jul 14, 2014
Clinical News

Trisomy 21 test regulatory update

GATC Biotech AG’s LifeCodexx AG subsidiary said Germany’s Federal Joint Committee (G-BA) issued a positive opinion allowing reimbursement of the company’s PraenaTest prenatal diagnostic for a trial period starting next year. During this period, a...
BC Week In Review | Aug 27, 2012
Company News

GATC sales and marketing update

GATC Biotech's LifeCodexx AG subsidiary launched PraenaTest in Germany, Switzerland, Austria and Liechtenstein to detect fetal trisomy 21 in maternal blood. The non-invasive prenatal diagnostic, which has CE Mark approval, is priced at €1,249.50 ($1,543.76)...
BC Week In Review | Apr 30, 2012
Clinical News

Trisomy 21 test diagnostic data

GATC Biotech's LifeCodexx AG subsidiary reported data from a European validation study in 522 maternal blood samples from pregnant women with a high risk of chromosomal alterations in their unborn child showing that the PraenaTest...
BC Extra | Apr 28, 2012
Clinical News

LifeCodexx reports validation data for trisomy 21 test

LifeCodexx AG said PraenaTest had 100% sensitivity and specificity for detecting fetal trisomy 21 in a European validation study of 522 maternal blood samples from pregnant women with a high risk of chromosomal alterations in...
BC Week In Review | Jan 16, 2012
Clinical News

Trisomy 21 test update

GATC Biotech's LifeCodexx AG subsidiary obtained over 500 blood samples in a European validation study of its LifeCodexx PraenaTest. The company plans to launch the test in German-speaking countries next quarter. GATC Biotech AG , Konstanz,...
BC Week In Review | Jul 18, 2011
Company News

Illumina, Sequenom deal

The companies will collaborate to seek regulatory approval of an in vitro diagnostic (IVD) version of Sequenom's Trisomy 21 prenatal Down syndrome laboratory-developed test (LDT). Sequenom plans to submit a regulatory application to FDA for...
BC Week In Review | Jul 4, 2011
Clinical News

Trisomy 21 test update

GATC Biotech's LifeCodexx AG subsidiary began a European validation study of its Trisomy 21 diagnostic test in over 500 samples. GATC Biotech AG , Konstanz, Germany   Product: Trisomy 21 test   Business: Diagnostic   Molecular...
BC Week In Review | Aug 16, 2010
Clinical News

SEQureDx Down syndrome test: Pilot trial started

Sequenom reported in its earnings that in June the company began a pilot study to evaluate its Trisomy 21 test in 450 clinical samples obtained from pregnant women identified as being at an increased risk....
BioCentury | May 31, 2010
Finance

Ebb & Flow Sequenom's angels

Sequenom's angels In an SEC filing last week, Sequenom Inc. (NASDAQ:SQNM) disclosed the investors who ponied up the $51.6 million private placement of 12.4 million shares at $4.15 on May 17. A large group of...
BioCentury | May 4, 2009
Finance

Sequenom Chronicles

Sequenom Chronicles Sequenom Inc. (NASDAQ:SQNM) fell 71% on the week after reporting after market close Wednesday that it delayed the expected June launch of its SEQureDx Trisomy 21 test for Down syndrome due to "employee...
Items per page:
1 - 10 of 18